דייויגו 10 מג Израиль - иврит - Ministry of Health

דייויגו 10 מג

eisai israel ltd., israel - lemborexant - טבליות מצופות פילם - lemborexant 10 mg - lemborexant

דייויגו 5 מג Израиль - иврит - Ministry of Health

דייויגו 5 מג

eisai israel ltd., israel - lemborexant - טבליות מצופות פילם - lemborexant 5 mg - lemborexant

זובירקס טבליות 400 מג Израиль - иврит - Ministry of Health

זובירקס טבליות 400 מג

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 400 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including intial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

זובירקס טבליות 200 מג Израиль - иврит - Ministry of Health

זובירקס טבליות 200 מג

glaxo smith kline (israel) ltd - aciclovir - טבליה - aciclovir 200 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox.

זובירקס טבליות מסיסות 800 מג Израиль - иврит - Ministry of Health

זובירקס טבליות מסיסות 800 מג

glaxo smith kline (israel) ltd - aciclovir - טבליות ניתנות לפיזור - aciclovir 800 mg - aciclovir - aciclovir - for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. for the prophylaxis of herpes simplex infections in immune-compromised patients. for the treatment of herpes zoster infections . for the treatment of chickenpox in the following groups: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving short or intermittent courses of aerosolized corticosteroids.